The U.S. Market for Over-the-Counter Allergy and Asthma Products (Table of Contents)

The U.S. Market for Over-the-Counter Allergy and Asthma Products


November 1, 2001
228 Pages - SKU: KLI521895
License type:
Online Download      US $3,250.00

1. Executive Summary


    1.1 Introduction
    1.2 Scope and Methodology
    1.3 Size and Growth of the Market

2. Introduction


    2.1 History and Growth of the OTC Market
    2.2 Industry Structure
    2.3 Overview of the Respiratory System
    2.4 Prevalence, Incidence
    2.5 Risk Factors
    2.6 Treatment Guidelines

3. Allergic Rhinitis Remedies


    3.1 Overview
    3.2 Description of Products

      3.2.1 Antihistamines
      3.2.2 Decongestants
      3.2.3 Mast Cell Stabilizers

    3.3 Rx-to-OTC Switches
    3.4 Generic Participation
    3.5 Market Size and Growth
    3.6 Competitive Analysis

4. Sinusitis Remedies


    4.1 Overview
    4.2 Description of Products

      4.2.1 Antihistamines
      4.2.2 Decongestants
      4.2.3 Combinations

    4.3 Rx-to-OTC Switches
    4.4 Generic Participation
    4.5 Market Size and Growth
    4.6 Competitive Analysis

5. Ocular Allergy Remedies


    5.1 Overview
    5.2 Description of Products

      5.2.1 Antihistamines
      5.2.2 Mast Cell Stabilizers

    5.3 Rx-to-OTC Switches
    5.4 Generic Participation
    5.5 Market Size and Growth
    5.6 Competitive Analysis

6. Asthma Products


    6.1 Overview
    6.2 Description of Products

      6.2.1 Bronchodilators

    6.3 Rx-to-OTC Switches
    6.4 Generic Participation
    6.5 Market Size and Growth
    6.6 Competitive Analysis

7. Potential OTC Allergy and Asthma Products


    7.1 Overview
    7.2 Description of Products

      7.2.1 Non-sedating Antihistamines

    7.3 Potential Market Size and Growth
    7.4 Potential Competitors

8. Issues and Trends Affecting the OTC Market


    8.1 Consumer Issues

      8.1.1 Education and Self-Medication
      8.1.2 Prescription vs. Over-the-Counter Cost

    8.2 Direct-to-Consumer Advertising

      8.2.1 Impact
      8.2.2 Cost

    8.3 Distribution
    8.4 Drug-Drug Interactions and Market Withdrawal
    8.5 Generic Activity and Impact
    8.6 Insurance and Reimbursement Issues
    8.7 Legislative and Regulatory Issues

9. Total Market Size and Forecast


    9.1 Overview
    9.2 Total Market Size and Forecast
    9.3 Potential Products and Market Forecast
    9.4 Competitor Analysis
    9.5 Market Analysis

10. Corporate Profiles


    10.1 Aventis Pharmaceuticals
    10.2 Bayer Consumer Care
    10.3 Bristol-Myers Products
    10.4 GlaxoSmtihKline Consumer Healthcare
    10.5 McNeil Consumer Healthcare
    10.6 Novartis Consumer Healthcare
    10.7 Pfizer, Inc.
    10.8 Pharmacia Corporation
    10.9 Schering-Plough
    10.10 Whitehall-Robins Healthcare
    10.11 Warner-Lambert Consumer Group

Appendix: Company Names and Addresses